Eiger BioPharmaceuticals Publishes Clinical Results of Lonafarnib in Hepatitis Delta Virus
News
Eiger BioPharmaceuticals Incorporated, a privately held biotechnology company focused on the research, development and commercialization of innovative therapies in viral hepatitis, recently announced their latest data on the first Phase 2a clinical ... Read more